Pharma/Biotech – USA, Europe, Asia and ROW Regulatory News – Feb 2025
USA
FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes
The U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog...
Asia Biotech, Biotech 2025, Biotech Insights, Biotech Updates, Europe Pharma, Pharma News, Pharma Regulations, Pharma Trends, Regulatory Affairs, ROW Regulatory, USA Regulations